Zhejiang Wolwo Bio-Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of immunotherapies. The company focuses on innovative allergen products for the diagnosis and treatment of allergic diseases for patients worldwide.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Zhejiang Wolwo Bio-Pharmaceutical A is scheduled to report its next quarterly earnings on 08/28/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Zhejiang Wolwo Bio-Pharmaceutical A last reported quarterly earnings on 4/24/2026 (Q1 2026). Earnings per share (EPS) came in at 0.73 CNY.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.